Navigation Links
Aware, Inc. Reports Third Quarter 2013 Financial Results
Date:10/28/2013

BEDFORD, Mass., Oct. 28, 2013 /PRNewswire/ -- Aware, Inc. (NASDAQ: AWRE), a leading supplier of biometrics software and services, today reported financial results for its third quarter ended September 30, 2013. 

Revenue for the third quarter of 2013 was $4.5 million, a decrease of 15% compared to $5.3 million in the same quarter last year. The net loss for the third quarter of 2013 was $1.2 million, or $0.05 per diluted share, which compares to net income of $10.3 million, or $0.46 per diluted share, for the same period a year ago. Net income in the third quarter of 2012 included a gain on the sale of patent assets of $15.2 million.  Operating income before patent related income in the third quarter of 2013 was a loss of $2.2 million compared to income of $1.4 million in the third quarter of 2012.

For the nine months ended September 30, 2013, revenue increased 5% to $14.9 million, compared to $14.2 million in the same period a year ago.  Net income for the nine months ended September 30, 2013 was $1.0 million, or $0.04 per diluted share. These results compared to net income of $66.3 million, or $3.03 per diluted share, for the same period a year ago. Year-to-date net income in 2012 included an $86.4 million gain on the sale of patent assets.  Operating income before patent related income for the first nine months of 2013 was $134,000 compared to $2.6 million for the same period a year ago.

Financial results for the three and nine month periods ended September 30, 2013 were materially affected by the Company's decision to shut down its DSL service assurance business.  This decision limited our ability to record revenue from our DSL service assurance business in the quarter.  We also incurred $2.8 million of costs to shutdown the business. Notwithstanding the impact on the quarter and year-to-date periods, we believe this action was necessary in light of the lack of historical profitability and the future outlook for this business.

Our biometrics business was and is unaffected by this decision and continues to perform well. We encourage you to read our third quarter Form 10-Q for more details on the financial performance of our company.

Rick Moberg, Aware's co-chief executive officer and chief financial officer, said, "While shutting down the DSL service assurance business was not an easy decision, we believe this action was in the best interests of the Company and its shareholders.  We are excited to move forward focused on growing our profitable biometrics business."

About Aware
Aware is a leading software and technology supplier for the biometrics and healthcare industries. Aware's biometrics software products and services are provided to solution vendors and system integrators for use by government agencies towards applications including border management, secure credentials, law enforcement, and national defense. Aware also provides standards-based medical imaging software products to the healthcare industry.  Aware is a publicly held company (Nasdaq: AWRE) based in Bedford, Massachusetts. www.aware.com

Safe Harbor Warning
Portions of this release contain forward-looking statements regarding future events and are subject to risks and uncertainties, such as estimates or projections of future revenue and earnings, and the growth of the biometrics markets. Aware wishes to caution you that there are factors that could cause actual results to differ materially from the results indicated by such statements.

General factors include, but are not limited to: our quarterly results are unpredictable and may fluctuate significantly; our business is subject to rapid technological change; we face intense competition from a wide range of competitors; our intellectual property is subject to limited protection; our business may be affected by our use of open source software; our business may be affected by government regulations; adverse economic conditions; and our ability to obtain or enforce patents could be affected by new laws, regulations or rules. Biometric factors include, but are not limited to: market acceptance of our biometric technologies and products; changes in contracting practices of government or law enforcement agencies; the failure of the biometrics market to experience continued growth; announcements or introductions of new technologies or products by our competitors; failures or problems in our biometric software products; delays in the adoption of new industry biometric standards; growth of proprietary biometric systems which do not conform to industry standards; our ability to sell services contracts in a manner that is consistent with our business model; our ability to deliver services contract milestones; and our dependence on third party contractors and consultants to deliver certain services contract milestones.

We refer you to the documents Aware files from time to time with the Securities and Exchange Commission, specifically the section titled Risk Factors in our annual report on Form 10-K for the fiscal year ended December 31, 2012 and other reports and filings made with the Securities and Exchange Commission.

Aware is a trademark or registered trademark of Aware, Inc.
Any other trademarks appearing herein are the property of their respective owners.

 AWARE, INCCONSOLIDATED STATEMENTS OF OPERATIONS(In thousands, except per share data)(unaudited)Three Months Ended
September 30,Nine Months Ended
September 30,2013201220132012Revenue:Software licenses$2,334$3,387$7,704$8,070Software maintenance1,0236613,1872,471Services9437242,1792,100Hardware sales--1,129-Royalties1704847371,599Total revenue4,4705,25614,93614,240Costs and expenses:Cost of hardware sales--813-Cost of services4944211,0751,138Research and development1,4521,4664,5044,431Selling and marketing9311,0692,9983,143General and administrative9228542,5802,915Exit costs2,832-2,832-Total costs and expenses6,6313,81014,80211,627Operating income (loss) before patent related income(2,161)1,4461342,613Gain on sale of patent assets-15,167-86,394Income from patent arrangement--780-Operating income (loss) after patent related income(2,161)16,61391489,007Other income27-2785Interest income8045239137Income (loss) from continuing operations before income taxes(2,054)16,6581,18089,229Provision for (benefit from) income taxes(901)6,57816923,248Income (loss) from continuing operations(1,153)10,0801,01165,981Income from discontinued operations, net of income taxes-217-360Net income (loss)($1,153)$10,297$1,011$66,341Basic net income (loss) per share:Basic net income (loss) per share from continuing operations($0.05)$0.45$0.04$3.05Basic net income per share from discontinued operations0.000.010.000.02Basic net income (loss) per share($0.05)$0.46$0.04$3.07Diluted net income (loss) per share:Diluted net income (loss) per share from continuing operations($0.05)$0.45$0.04$3.01Diluted net income per share from discontinued operations0.000.010.000.02Diluted net income (loss) per share($0.05)$0.46$0.04$3.03Weighted-average shares – basic22,57122,33922,53321,609Weighted-average shares - diluted22,57122,50122,62321,888Comprehensive income (loss):Net income (loss) ($1,153)$10,297$1,011$66,341Other comprehensive income:Unrealized gains (losses) on available for sale securities(26)(4)(6)16Comprehensive income (loss)($1,179)$10,293$1,005$66,357 AWARE, INCCONDENSED CONSOLIDATED BALANCE SHEETS(In thousands)(unaudited)September 30,2013December 31,2012 

ASSETSCash and investments$78,380$73,084Accounts receivable, net2,7544,578Property and equipment, net5,6445,904Deferred tax assets1,5751,760Other assets, net1,294528Total assets$89,647$85,854 

 

LIABILITIES AND STOCKHOLDERS' EQUITYTotal current liabilities$6,350$3,639Long-term deferred revenue40319Total stockholders' equity83,25781,896Total liabilities and stockholders' equity$89,647$85,854 


'/>"/>
SOURCE Aware, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. Aware, Inc. Reports Second Quarter 2013 Financial Results
2. Aware, Inc. Reports First Quarter 2013 Financial Results
3. NASDAQ Sets Ex-Dividend Date for Aware, Inc.s Special Cash Dividend of $1.80 Per Share
4. Aware, Inc. Declares Special Cash Dividend of $1.80 Per Share, or Approximately $40 Million in Total
5. Aware, Inc. Reports Third Quarter 2012 Financial Results
6. Aware, Inc. Reports Second Quarter 2012 Financial Results
7. Aware, Inc. Reports First Quarter 2012 Financial Results
8. U-M technical reports examine hydraulic fracturing in Michigan
9. NOAA reports discovery of table coral, Acropora cytherea, off Oahu
10. University of Florida reports 2012 US shark attacks highest since 2000
11. Invading species can extinguish native plants despite recent reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/7/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... the LEERINK Partners 6th Annual Global Healthcare Conference at ... 15, 2017 at 10 a.m. Eastern Time. ... accessed at http://wsw.com/webcast/leerink28/zbh .  The webcast will be ... Investor Relations website at http://investor.zimmerbiomet.com . ...
(Date:2/2/2017)... JACKSONVILLE, Fla. , Feb. 2, 2017 /PRNewswire/ ... ), a clinical-stage immuno-oncology company specializing in the ... vaccines for the treatment of cancer and metastatic ... multi-gram scale-up and GMP manufacturing of a second ... T-cell vaccine targeting folate receptor alpha. The manufactured ...
(Date:1/30/2017)... FRANCISCO , Jan. 30, 2017   Invitae ... the fastest growing genetic information companies, today announced that ... financial results and provide 2017 guidance on Monday, February ... conference call that day at 4:45 p.m. Eastern / ... Invitae,s management team will briefly review financial results, guidance, ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... RADNOR, Pa., Feb. 24, 2017  VWR Corporation (NASDAQ: VWR), ... to laboratory and production customers, today reported its financial results ... 2016. Highlights: 4Q16 record ... up 1.0% on an organic basis. ... on an organic basis, while the Americas net sales increased ...
(Date:2/23/2017)... Financial ... data, unaudited)Three Months Ended December 31,Twelve Months Ended December ... $           300$ ... Net Product Revenue 3539(10)%9498(4)%Kuvan Net ... Revenue  756025%297303(2)%Vimizim Net Product Revenue ...
(Date:2/23/2017)... , Feb. 23, 2017  MIODx announced ... for two key immunotherapy technologies from the University ... provides a method to monitor a patient for ... PD-L1 and CTLA-4.  The second license extends the ... patient is likely to have an immune-related adverse ...
(Date:2/23/2017)... Feb. 23, 2017  Imanis Life Sciences announced ... of oncolytic vaccinia viruses for virotherapy research. These ... of Genelux,s proprietary, vaccinia virus-based technology platform for ... enter into a partnership with Genelux to offer ... viruses for use in research," said Dr. ...
Breaking Biology Technology: